Nyrada Inc.

A$0.49As of Sun 8 Nov 2026, 12:00 UTC
ASX:NYRHealthcare
Country Australia
PE (Fwd) •••
TSR 7Y CAGR 13.11%
Div yield —
ROE (99.95%)
Biotechnology
Beta (5Y) 0.96
PE TTM —
TSR TTM (38.89%)
Mkt cap A$122.6M
ROIC (64.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.61
23.26%
221.52%
Hold 0|7|7|11|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
27.52%
15.98%
5.95%
3.81%
Revenue$M
10.24
10.65
10.35
10.22
1.84%
7.03%
3.27%
1.69%
Peers (US$84.17M)
Cap (US$)
PE
84.80M
3.385x
84.40M
—
Capital
TTM
5Y
10Y
Leveragex
0.291
0.263
0.239
EBIT/Intx
0.901
0.178
0.161
Own earn%
147.57
(167.65)
(161.59)
Sh yield%
45.88
16.10
16.10
Owners
Insiders/Inst%
0.49
82.21
Short interest%
2.04
SBC / revenue%
4.93
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
2–5
$1 testx
—
Incr. ROIC%
4